RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Eurofarma
E

Eurofarma portfolio

Eurofarma has 2 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 1.
Capital in their rounds: $202.5M.
Latest deal: PsiThera · Dec 16, 2025.
About this page

Its most recent investment on record is PsiThera's $47.5M Series A round in December 2025, alongside Lightstone Ventures, Samsara Biocapital, YK Bioventures and 1 other. By category, its portfolio leans toward Health and bio (2) and Manufacturing and industrial (1). It has co-invested with Samsara Biocapital, Lightstone Ventures and YK Bioventures, most often Samsara Biocapital (2 rounds).

What Eurofarma invests in

How Eurofarma invests

StageDealsCapital in rounds
Series B+ 1 50%$155M
Series A 1 50%$47.5M
YearDealsCapital in rounds
2023 1 50%$155M
2025 1 50%$47.5M

Eurofarma portfolio companies

CompanyRound with EurofarmaTotal raisedLatest raise
PPsiThera
Health and bio
 Series A · $47.5M$47.5MDec 16, 2025
Series A
AAbcuro
Health and bio
 Series B+ · $155M$463MAug 18, 2026
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name Eurofarma. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Eurofarma, which is a subset of its real portfolio. API: /api/v1/investors/eurofarma (get a free API key). More: the most active VC firms and new venture capital funds.